Read + Share
Amedeo Smart
Independent Medical Education
Slomski A. Anti-Tau Antibody Semorinemab Fails to Slow Alzheimer Disease. JAMA 2022;328:415.PMID: 35916858
Email
LinkedIn
Facebook
Twitter
Privacy Policy
